138 related articles for article (PubMed ID: 11708931)
1. 5,6-Diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors.
Giovannoni MP; Piaz VD; Kwon BM; Kim MK; Kim YK; Toma L; Barlocco D; Bernini F; Canavesi M
J Med Chem; 2001 Nov; 44(24):4292-5. PubMed ID: 11708931
[TBL] [Abstract][Full Text] [Related]
2. Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N'-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitors.
Gelain A; Bettinelli I; Barlocco D; Kwon BM; Jeong TS; Cho KH; Toma L
J Med Chem; 2005 Dec; 48(24):7708-13. PubMed ID: 16302810
[TBL] [Abstract][Full Text] [Related]
3. Novel 3-arylamino- and 3-cycloalkylamino-5, 6-diphenyl-pyridazines active as ACAT inhibitors.
Toma L; Giovannoni MP; Vergelli C; Dal Piaz V; Kwon BM; Kim YK; Gelain A; Barlocco D
Arch Pharm (Weinheim); 2002; 335(11-12):563-6. PubMed ID: 12596221
[TBL] [Abstract][Full Text] [Related]
4. 3-heptylamino-5-phenylpyridazine derivatives as analogues of Acyl-CoA: cholesterol acyltransferase inhibitors containing the N-heptyl-N'-arylureidic moiety.
Gelain A; Barlocco D; Kwon BM; Jeong TS; Im KR; Legnani L; Toma L
Arch Pharm (Weinheim); 2006 Dec; 339(12):645-51. PubMed ID: 17109461
[TBL] [Abstract][Full Text] [Related]
5. Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
Astles PC; Ashton MJ; Bridge AW; Harris NV; Hart TW; Parrott DP; Porter B; Riddell D; Smith C; Williams RJ
J Med Chem; 1996 Mar; 39(7):1423-32. PubMed ID: 8691472
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
[TBL] [Abstract][Full Text] [Related]
7. Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitors.
Gelain A; Barlocco D; Kwon BM; Jeong TS; Im KR; Legnani L; Toma L
J Med Chem; 2008 Mar; 51(5):1474-7. PubMed ID: 18284184
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of acyl CoA:cholesterol acyltransferase.
Vaccaro W; Amore C; Berger J; Burrier R; Clader J; Davis H; Domalski M; Fevig T; Salisbury B; Sher R
J Med Chem; 1996 Apr; 39(8):1704-19. PubMed ID: 8648610
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
[TBL] [Abstract][Full Text] [Related]
10. Studies on acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative.
Kusunoki J; Aragane K; Yamaura T; Ohnishi H
Jpn J Pharmacol; 1995 Mar; 67(3):195-203. PubMed ID: 7630037
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine and analogues as inhibitors of acyl-CoA: cholesterol O-acyltransferase.
Ohishi K; Aiyama R; Hatano H; Yoshida Y; Wada Y; Yokoi W; Sawada H; Watanabe T; Yokokura T
Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):830-9. PubMed ID: 11456087
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
Maduskuie TP; Wilde RG; Billheimer JT; Cromley DA; Germain S; Gillies PJ; Higley CA; Johnson AL; Pennev P; Shimshick EJ
J Med Chem; 1995 Mar; 38(7):1067-83. PubMed ID: 7707310
[TBL] [Abstract][Full Text] [Related]
13. Chemical modification and structure-activity relationships of pyripyropenes. 2. 1,11-Cyclic analogs.
Obata R; Sunazuka T; Kato Y; Tomoda H; Harigaya Y; Omura S
J Antibiot (Tokyo); 1996 Nov; 49(11):1149-56. PubMed ID: 8982344
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates.
Lee HT; Roark WH; Picard JA; Sliskovic DR; Roth BD; Stanfield RL; Hamelehle KL; Bousley RF; Krause BR
Bioorg Med Chem Lett; 1998 Feb; 8(3):289-94. PubMed ID: 9871672
[TBL] [Abstract][Full Text] [Related]
15. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
[TBL] [Abstract][Full Text] [Related]
16. Purpactins, new inhibitors of acyl-CoA:cholesterol acyltransferase produced by Penicillium purpurogenum. I. Production, isolation and physico-chemical and biological properties.
Tomoda H; Nishida H; Masuma R; Cao J; Okuda S; Omura S
J Antibiot (Tokyo); 1991 Feb; 44(2):136-43. PubMed ID: 1750931
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N'-arylureas.
Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
J Med Chem; 1998 Jun; 41(13):2390-410. PubMed ID: 9632372
[TBL] [Abstract][Full Text] [Related]
18. Acyl-CoA: cholesterol acyltransferase inhibitory activity of ginseng sapogenins, produced from the ginseng saponins.
Kwon BM; Kim MK; Baek NI; Kim DS; Park JD; Kim YK; Lee HK; Kim SI
Bioorg Med Chem Lett; 1999 May; 9(10):1375-8. PubMed ID: 10360739
[TBL] [Abstract][Full Text] [Related]
19. Acyl-CoA:cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
Harris NV; Smith C; Ashton MJ; Bridge AW; Bush RC; Coffee EC; Dron DI; Harper MF; Lythgoe DJ; Newton CG
J Med Chem; 1992 Nov; 35(23):4384-92. PubMed ID: 1447739
[TBL] [Abstract][Full Text] [Related]
20. Effect of membrane environment on inhibition of acyl-CoA:cholesterol acyltransferase by a range of synthetic inhibitors.
Harte RA; Yeaman SJ; Jackson B; Suckling KE
Biochim Biophys Acta; 1995 Oct; 1258(3):241-50. PubMed ID: 7548193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
